The PI3K/mechanistic target of rapamycin kinase (mTOR) signaling pathway is also affected by genetic mutations in both NF1 and NF2, with its aberrant activation driving cell growth, proliferation, and survival, thereby playing a pivotal role in tumor development [333]. The gene discussed is MTOR; the disease is neoplasm.